Clinical trials
Pediatric Oncology clinical trials
Below are recruiting pediatric oncology clinical trials, each written for real people, not researchers. We’re tracking 66 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07632560Recruiting
Understanding Taste and Eating During Cancer Treatment in Kids
This study looks at how cancer treatment affects how children taste food and eat. Researchers will test your child's ability to taste and smell, and ask about eating habits, to help doctors better support kids during cancer care.
LyonAges 7–17 - NCT07368582Recruiting
Rehabilitation study for young cancer patients in Italy
This study looks at how rehabilitation services help children, teens, and young adults with cancer. It includes people at any stage of treatment or after treatment ends.
Bergamo, ItaliaAges birth–24 years - NCT03803735Recruiting
Hospital cancer registry for children in French-speaking Africa
This trial is a hospital-based registry that collects information about children and teens with cancer as they receive treatment. It may help researchers better understand cancer care in this region and improve future planning and treatment.
OuagadougouAges 1 day–18 years - NCT06981156Recruiting
Study of pediatric brain and spine tumor exams
This study tests a shorter way to check the brain and nervous system in children with brain or spine tumors. It aims to see if the new exam is as good as the standard one.
Madison, WisconsinAges 1–17 - NCT07420101Recruiting
Reducing scan anxiety in caregivers with meditation
This study tests if meditation programs can help ease the anxiety caregivers feel when a loved one with cancer has a routine scan. You will be asked to follow a meditation program and possibly eat a raisin as part of a mindfulness exercise.
Hartford, ConnecticutAges 18 years+ - NCT07647471Recruiting
Exercise program for children starting cancer treatment
This study tests whether gentle exercise during cancer treatment helps children feel better and recover faster. Researchers will guide kids through age-appropriate activities while they receive their cancer therapy.
BerlinAges 3–18 - NCT05592132Recruiting
Virtual reality to help children handle cancer treatment pain
This trial studies whether virtual reality can reduce pain and discomfort during painful medical procedures for children getting care for benign (non-cancerous) tumors or cancer. It may help make treatments feel easier for you and your child during procedures.
Saint-DenisAges 6–18 - NCT06892158Recruiting
Massage therapy for sleep in teens with cancer
This trial studies if massage therapy can help teenagers and young adults with cancer sleep better while they are in the hospital. Participants will receive massage sessions and answer questions about their sleep.
Washington D.C., District of ColumbiaAges 12–21 - NCT06033183Recruiting
Study of radiation sensitivity in children with cancer
This study looks at how children's bodies respond to radiation therapy for certain cancers. By analyzing blood samples, researchers hope to learn why some children experience more side effects, which could help personalize future treatments.
CaenAges 3–18 - NCT07288476Recruiting
Spanish videos for parents of kids with cancer
This study creates and tests Spanish educational videos for parents of children with cancer. It aims to help Spanish-speaking families better understand their child's cancer care.
Aurora, ColoradoAges 18 years+ - NCT05058508Recruiting
Exercise program for children and young adults on new cancer treatment
This study tests an exercise program for young people newly diagnosed with cancer who are starting treatment like chemotherapy. It aims to see whether safely adding exercise can be part of care during the first treatment cycles.
Charlotte, North CarolinaAges 2–25 - NCT07202507Recruiting
Can a sensory room help with anxiety during chemo?
This study tests if a special relaxing room (SNOEZELEN) can help reduce anxiety in children and teens getting chemotherapy. The goal is to see if the room makes the hospital stay less stressful.
LilleAges 8–18 - NCT05384288Recruiting
How kids with blood cancers respond to the flu vaccine
This study looks at how children with blood cancers respond to the seasonal flu shot. It may help doctors understand what protection the vaccine provides for pediatric oncology patients.
Memphis, TennesseeAges Up to 18 years - NCT02315599Enrolling by invitation
Follow-up for delayed side effects after gene-cell therapy
This study checks people for delayed side effects after receiving gene-based cell therapy from the NIH. It helps doctors learn what problems may happen later and how to monitor them safely.
Bethesda, MarylandAges 1–99 - NCT06346782Recruiting
Online parenting support for children with cancer
This study tests an online therapy program that helps parents manage challenging behaviors in children with cancer. If you join, you'll learn skills through video coaching sessions with a therapist, all from the comfort of your home.
St. Petersburg, FloridaAges Any age - NCT07696065RecruitingEarly Phase 1
Palliative care support for kids in early cancer trials
This study tests adding palliative care—extra comfort and quality-of-life support—for children and young adults being considered for early-phase cancer trials. It involves patients, their families, and their doctors.
Phoenix, ArizonaAges birth–25 years - NCT07156435RecruitingPhase 1
Vyxeos and Clofarabine for Children with Relapsed AML
This trial tests a combination of two chemotherapy drugs, Vyxeos (liposomal daunorubicin and cytarabine) and clofarabine, in children and young adults whose acute myeloid leukemia (AML) has come back or hasn't responded to standard treatment. The goal is to see if this combination can help control the leukemia.
ViennaAges 1–21 - NCT05994690RecruitingPhase 3
Newly diagnosed pediatric AML trial with extra treatment options
This trial studies different treatment plans for children and teens newly diagnosed with AML (a type of blood cancer). Depending on the child's tumor markers and risk group, they may be offered an extra drug (quizartinib) or a targeted antibody (Mylotarg) to see if it improves outcomes.
Utrecht, UtrechtAges 1 day–18 years - NCT06262438RecruitingPhase 2
Quizartinib plus chemo for children with FLT3-ITD AML
This study adds a targeted drug called quizartinib to standard chemotherapy for children with a certain type of acute myeloid leukemia (AML) that has a FLT3-ITD gene change. The goal is to see if this combination is safe and effective for treating newly diagnosed patients.
Utrecht, UtrechtAges 1 month–18 years - NCT04925609RecruitingPhase 1/Phase 2
Brigatinib for young people with ALK-positive cancer
This trial tests brigatinib, a targeted pill medicine, in children and young adults with ALK-positive cancers (including ALCL and IMT, plus some other solid tumors). It’s designed to see how well it works and what side effects it causes in people whose tumors have a specific ALK change.
ParisAges 1–25 - NCT06019130RecruitingPhase 2
Nivolumab for newly diagnosed nasopharyngeal cancer
This trial tests whether the immunotherapy drug nivolumab (Opdivo) can help treat nasopharyngeal cancer in both children and adults. It is for people who have just been diagnosed and have not yet received any cancer treatment.
AachenAges 3 years+ - NCT07522905Recruiting
Virtual Movement Therapy for Kids With Leukemia in Remission
This study tests a fun virtual movement program where children who have finished leukemia treatment exercise together with a healthy friend online. The goal is to help improve their physical strength, coordination, and social skills after cancer treatment.
BratislavaAges 5–12 - NCT07490548Enrolling by invitation
Lifestyle, mental health, and quality of life in childhood cancer survivors
This trial looks at how following a healthy lifestyle affects mental well-being and quality of life in children and teens who have finished cancer treatment. It is meant for those who are now coming back for follow-up visits.
CuencaAges 3–17 - NCT07399821RecruitingPhase 1/Phase 2
Imaging study of anti-GD2-800CW in neuroblastoma
This trial tests a special dye (anti-GD2-800CW) that lights up neuroblastoma cells during surgery, helping surgeons see and remove more of the tumor. It is for children with neuroblastoma who are scheduled to have surgery.
UtrechtAges 1–18
Hear when a new Pediatric Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pediatric oncology?
- Yes. Clin2 currently lists 66 recruiting pediatric oncology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pediatric oncology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pediatric oncology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.